CN104383146A - Drug for fumigating neck - Google Patents

Drug for fumigating neck Download PDF

Info

Publication number
CN104383146A
CN104383146A CN201410716796.0A CN201410716796A CN104383146A CN 104383146 A CN104383146 A CN 104383146A CN 201410716796 A CN201410716796 A CN 201410716796A CN 104383146 A CN104383146 A CN 104383146A
Authority
CN
China
Prior art keywords
parts
medicament
cervical region
stifling
strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410716796.0A
Other languages
Chinese (zh)
Inventor
莫海棠
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410716796.0A priority Critical patent/CN104383146A/en
Publication of CN104383146A publication Critical patent/CN104383146A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488—Pueraria (kudzu)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/648—Myriapods, e.g. centipedes or millipedes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282—Artemisia, e.g. wormwood or sagebrush
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/486—Millettia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/62—Nymphaeaceae (Water-lily family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Insects & Arthropods (AREA)
  • Inorganic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention discloses a drug for fumigating neck. The drug is prepared from the following medicines in parts by weight: 50-60 parts of the root of kudzu vine, 15-20 parts of cassia twigs, 35-40 parts of caulis spatholobi, 30-35 parts of keel, 30-35 parts of oyster, 15-20 parts of earthworms, 10-15 parts of the seed of cowherb, 10-15 parts of wintercreeper, 10-15 parts of folium apocyni veneti, 5-10 parts of rush, 15-20 parts of lotus seeds, 10-15 parts of wormwood, 1-2 parts of centipede and 3-5 parts of gypsum. The neck is fumigated, so that muscle strain of the neck is alleviated and eliminated, and the drug has good treatment effects on neck muscle soreness and pain and joint strain caused by long-term non-relaxed neck muscle. In addition, the soreness and strain symptoms of muscles on other parts due to long-term exercise can be alleviated and treated.

Description

A kind of medicament of stifling cervical region
Technical field
The present invention relates to fumigation medicament field, be specifically related to a kind of medicament of stifling cervical region.
 
Background technology
In work and life, the long-time supporting head part of cervical vertebra, easily causes cervical vertebra joint, sense of discomfort that musculi colli group occurs fatigue, aches, and this is the prompting from health instinct, and cervical region needs to have a rest.
Using herbal fumigation therapy to physical strain state of releiving, is a kind of simple, and effective Therapeutic Method, the method is used in Be very effective on neck fatigue of releiving.
 
Summary of the invention
The object of the invention is to provide a kind of Chinese medicine, by stifling means, be mainly used in treating the symptom that the muscles and bones muscle arthrosis that causes because cervical region is in holding state is for a long time ached, its muscular strain not loosening for a long time other positions for the treatment of and cause also has good therapeutic effect.
For achieving the above object, the present invention adopts following technological means:
A medicament for stifling cervical region, is mixed by ratio of weight and the number of copies by following medicine:
Radix Puerariae 50-60 part, Ramulus Cinnamomi 15-20 part, Caulis Spatholobi 35-40 part, Os Draconis 30-35 part, Concha Ostreae 30-35 part, Pheretima 15-20 part, Semen Vaccariae 10-15 part, Caulis Seu Folium Euonymi Fortunei 10-15 part, Folium Apocyni Veneti 10-15 part, Medulla Junci 5-10 part, Semen Nelumbinis 15-20 part, Folium Artemisiae Argyi 10-15 part, Scolopendra 1-2 part, Gypsum Fibrosum 3-5 part.
Above-mentioned each raw material is all on the books in the Pharmacopoeia of the People's Republic of China (version in 2010).
Effective part of the present invention is, uses Radix Puerariae for improving cerebral blood flow and expansion of cerebral vascular has certain effect; The rich blood vessel of cervical region, uses heating power heating Radix Puerariae to fumigate the blood circulation that cervical region can accelerate to promote cervical region; The medicaments such as Ramulus Cinnamomi, Caulis Spatholobi, Pheretima, Semen Vaccariae can accelerate velocity of blood flow in a heated condition, soothing the channels and quicking the network vessels, anti-inflammatory analgesic, in addition, use Folium Artemisiae Argyi stifling can dispelling cold and removing dampness, wind-expelling pain-stopping effect, have good result for symptom such as treatment rheumatic arthritis, headache, wind syndrome of head etc., also have in addition relieving asthma, antitussive, eliminate the phlegm, antiviral effect; Use the Scolopendra of a small amount of band poison to play treating the poisonous disease with poisonous drugs during stifling cervical region, play the therapeutic effect of the part toxin pulled out in cervical lymph position.
Detailed description of the invention
The invention discloses a kind of medicament of stifling cervical region, those skilled in the art can use for reference present disclosure, and appropriate reconstruction technological parameter realizes the making of this product.Special needs to be pointed out is, all similar replacements and change apparent to those skilled in the art, they are all deemed to be included in the present invention.The medicament of stifling cervical region of the present invention have passed through preferred embodiment and has been described, related personnel obviously can not depart from content of the present invention, spirit and scope methods and applications as herein described are changed or suitably change with combination, realize and apply the technology of the present invention.
If no special instructions, the test material related in a specific embodiment all can freely be buied from market or otherwise obtain.
Be described below in conjunction with specific embodiment:
Embodiment 1
A medicament for stifling cervical region, is mixed by ratio of weight and the number of copies by following medicine:
Radix Puerariae 50 parts, Ramulus Cinnamomi 15 parts, Caulis Spatholobi 35 parts, Os Draconis 35 parts, Concha Ostreae 35 parts, Pheretima 10 parts, Semen Vaccariae 13 parts, Caulis Seu Folium Euonymi Fortunei 13 parts, Folium Apocyni Veneti 13 parts, Medulla Junci 5 parts, 15 parts, Semen Nelumbinis, Folium Artemisiae Argyi 10 parts, Scolopendra 2 parts, 5 parts, Gypsum Fibrosum.
Embodiment 2
A medicament for stifling cervical region, made by ratio of weight and the number of copies by following medicine:
Radix Puerariae 55 parts, Ramulus Cinnamomi 17 parts, Caulis Spatholobi 38 parts, Os Draconis 33 parts, Concha Ostreae 33 parts, Pheretima 18 parts, Semen Vaccariae 10 parts, Caulis Seu Folium Euonymi Fortunei 10 parts, Folium Apocyni Veneti 10 parts, Medulla Junci 10 parts, 20 parts, Semen Nelumbinis, Folium Artemisiae Argyi 15 parts, Scolopendra 1 part, 3 parts, Gypsum Fibrosum.
Embodiment 3
A medicament for stifling cervical region, made by ratio of weight and the number of copies by following medicine:
Radix Puerariae 60 parts, Ramulus Cinnamomi 20 parts, Caulis Spatholobi 40 parts, Os Draconis 30 parts, Concha Ostreae 30 parts, Pheretima 15 parts, Semen Vaccariae 15 parts, Caulis Seu Folium Euonymi Fortunei 15 parts, Folium Apocyni Veneti 15 parts, Medulla Junci 8 parts, 18 parts, Semen Nelumbinis, Folium Artemisiae Argyi 18 parts, Scolopendra 1.5 parts, 4 parts, Gypsum Fibrosum.
Treatment example
King's ××, 26 years old, IT practitioner, throughout the year coding before computer, owing to keeping using computer for a long time, lessly loosened cervical region and cause neck strain, having the sensation be tightened up, separately with slight dizzy phenomenon.
Use embodiment 1 medicament to use electric heating to fumigate medicated pillow to fumigate, every 3 days once, and after using 3 times, cervical region feels that muscle is comparatively light, and when using the 7th time, dizziness phenomenon no longer occurs; After stopping using 1 month after using 10 times, operationally suitably have a rest, carry out neck movement, do not have cervical region to be tightened up sensation and occur with dizzy phenomenon, and do not find any side effect at treatments period.
Woods ××, king's ××, 31 years old, 29 years old, builder, often need ready-mixed concrete, because strenuous exercise that is long-time, high strength makes each muscle of whole body have strain in various degree, especially during ready-mixed concrete, head inclination observation concrete situation makes musculi colli strain situation even more serious, and there is pain phenomenon in each joint of cervical region.
Woods ×× uses embodiment 2 medicament to add water boil to carry out cervical region and fumigate, every 2 days 3 times, use and feel that musculi colli has and loosens sense for 5 times afterwards, therefore woods ×× is by pharmacy fumigation back, shoulders etc. are owing to working fatigue and cause the position of muscular strain, the treatment that same maintenance is 2 days 3 times, the 7th time time, muscular sensation loosens comfortable, and notify I and king's ××, woods ×× is when use the 10th treatment cervical region, cervical pain makes moderate progress, only there is pain when lifting too violent up and down, when the 11st treatment shoulder back muscle strain, sensation has change greatly, during motion, muscle is unlikely to excessively sour swollen, after treatment cervical region the 21st time, cervical pain disappears, motion cervical motion is sensitive, the acid for the treatment of shoulder muscle of back is swollen the 15th time time, sensation muscle is more comfortable after working long hours, the swollen anesthesia of acid obtains obvious, and do not find any side effect at treatments period,
King's ×× uses embodiment 1 medicament to add water boil to carry out cervical region and fumigate, every 2 days 3 times, use and feel that musculi colli has and loosens sense for 5 times afterwards, pharmacy fumigation takeed on after back obtains good result suggestion listening to woods ××, the treatment that same maintenance is 2 days 3 times, the 6th time time, muscular sensation loosens comfortable, king's ×× is when use the 9th treatment cervical region, cervical pain makes moderate progress, only there is pain when lifting too violent up and down, when the 12nd treatment shoulder back muscle strain, sensation has change greatly, during motion, muscle is unlikely to excessively sour swollen, after treatment cervical region the 21st time, cervical pain disappears, motion cervical motion is sensitive, the acid for the treatment of shoulder muscle of back is swollen the 13rd time time, sensation muscle is more comfortable after working long hours, the swollen anesthesia of acid obtains obvious, and do not find any side effect at treatments period,
Liu's ××, 38 years old, truck man, need to concentrate owing to often driving lorry, cervical region felt tired uncomfortable, and has the phenomenon of cervical spondylosis, and side-to-side movement head and rotation head skeleton have slight sound, and joint is tingle.
Liu's ×× is owing to often going on business, therefore use the medicine of embodiment 3 to put into add water boil to put into insulation heating pad to carry out cervical region hot compress, or use and add water boil and carry out the stifling two kinds of means of cervical region and walk abreast, every 3 days 2 times, sensation cervical region is comfortable afterwards to use 6 times, continue again to use, disappear to the slight sound of neck movement skeleton when the 9th time, cervical region tingle transference cure when the 11st time, treats 12 times altogether, feel good, and do not find any side effect at treatments period.
It should be noted that, above-mentioned is only better case study on implementation of the present invention, is not used for limiting protection scope of the present invention, and equal conversion done on the basis of above-described embodiment all belongs to protection scope of the present invention.The preparation of pharmaceutical composition hard capsule: resveratrol composition: 20%; Dextrin: 60%; To drop in mixer mixing 10 minutes, add ethanol 1% as wetting agent, mix 5 ~ 10 minutes, mixed material pelletization, drying, add microcrystalline Cellulose 19%, granulate, capsule-filling, obtain hard capsule.
Embodiment 13:
The preparation of pharmaceutical composition hard capsule: resveratrol composition: 50%; Dextrin: 40%; To drop in mixer mixing 20 minutes, add ethanol 2% as wetting agent, mix 10 minutes, mixed material pelletization, drying, add microcrystalline Cellulose 8%, granulate, capsule-filling, obtain hard capsule.
Embodiment 14:
The preparation of pharmaceutical composition hard capsule: resveratrol composition: 29%; Dextrin: 50%; To drop in mixer mixing 30 minutes, add ethanol 1% as wetting agent, mix 5 minutes, mixed material pelletization, drying, add microcrystalline Cellulose 20%, granulate, capsule-filling, obtain hard capsule.
Embodiment 15:
The preparation of pharmaceutical composition hard capsule: resveratrol composition: 28%; Dextrin: 60%; To drop in mixer mixing 30 minutes, add ethanol 2% as wetting agent, mix 5 minutes, mixed material pelletization, drying, add microcrystalline Cellulose 10%, granulate, capsule-filling, obtain hard capsule.
Embodiment 16:
The preparation of medicament composition dropping pills agent: resveratrol composition: 80%; Polyethylene Glycol: 20% mix homogeneously, heating, move into the drip irrigation of pill dripping machine, medicinal liquid drops in low temperature liquid Paraffin, and removing liquid Paraffin, selects ball, obtain drop pill.
Embodiment 17:
The preparation of medicament composition dropping pills agent: resveratrol composition: 95%; Polyethylene Glycol: 5% mix homogeneously, heating, move into the drip irrigation of pill dripping machine, medicinal liquid drops in low temperature liquid Paraffin, and removing liquid Paraffin, selects ball, obtain drop pill.Embodiment one:
The weight ratio of resveratrol, Radix Rhodiolae, Radix Ginseng, Radix Et Caulis Acanthopanacis Senticosi is: resveratrol: 30%; Radix Rhodiolae: 50%; Radix Ginseng: 10%; Radix Et Caulis Acanthopanacis Senticosi: 10%.After mixing Radix Rhodiolae, Radix Ginseng, Radix Et Caulis Acanthopanacis Senticosi can be all crude drug or be all the compositions of extract, also can be a kind of or the compositions of two kinds of crude drugs and another two kinds or a kind of extract.Described extract extracts by the method for prior art with crude drug and obtains.
Embodiment two:
The weight ratio of resveratrol, Radix Rhodiolae, Radix Ginseng, Radix Et Caulis Acanthopanacis Senticosi is: resveratrol: 40%; Radix Rhodiolae: 30%; Radix Ginseng: 25%; Radix Et Caulis Acanthopanacis Senticosi: 5%.All the other conditions are identical with embodiment 1.
Embodiment three:
The weight ratio of resveratrol, Radix Rhodiolae, Radix Ginseng, Radix Et Caulis Acanthopanacis Senticosi is: resveratrol: 60%; Radix Rhodiolae: 25%; Radix Ginseng: 10%; Radix Et Caulis Acanthopanacis Senticosi: 5%.All the other conditions are identical with embodiment 1.
Embodiment four:
The weight ratio of resveratrol, Radix Rhodiolae, Radix Ginseng, Radix Et Caulis Acanthopanacis Senticosi is: resveratrol: 30%; Radix Rhodiolae: 45%; Radix Ginseng: 15%; Radix Et Caulis Acanthopanacis Senticosi: 10%.All the other conditions are identical with embodiment 1.
Embodiment four:
The weight ratio of resveratrol, Radix Rhodiolae, Radix Ginseng, Radix Et Caulis Acanthopanacis Senticosi is: resveratrol: 40 %; Radix Rhodiolae: 25%; Radix Ginseng: 30%; Radix Et Caulis Acanthopanacis Senticosi: 5%.All the other conditions are identical with embodiment 1.
Embodiment five:
The weight ratio of resveratrol, Radix Rhodiolae, Radix Ginseng, Radix Et Caulis Acanthopanacis Senticosi is: resveratrol: 40 %; Radix Rhodiolae: 30%; Radix Ginseng: 10%; Radix Et Caulis Acanthopanacis Senticosi: 20%.All the other conditions are identical with embodiment 1.
Embodiment six:
The weight ratio of resveratrol, Radix Rhodiolae, Radix Ginseng, Radix Et Caulis Acanthopanacis Senticosi is: resveratrol: 42 %; Radix Rhodiolae: 25%; Radix Ginseng: 15%; Radix Et Caulis Acanthopanacis Senticosi: 18%.All the other conditions are identical with embodiment 1.
Embodiment seven:
The weight ratio of resveratrol, Radix Rhodiolae, Radix Ginseng, Radix Et Caulis Acanthopanacis Senticosi is: resveratrol: 50%; Radix Rhodiolae: 30%; Radix Ginseng: 18%; Radix Et Caulis Acanthopanacis Senticosi: 12%.All the other conditions are identical with embodiment 1.
Embodiment eight:
The preparation of medicinal composition soft capsule agent: resveratrol composition: 28%; Cera Flava: 10%; Polyethylene Glycol: 54%; Tween: 8% is mixed and made into capsule liquid, separately makes capsule material glue by gelatin, glycerol, purified water, capsule liquid and capsule material glue is made soft capsule by capsule filling machine.
Embodiment nine:
The preparation of medicinal composition soft capsule agent: resveratrol composition: 34%; Cera Flava: 5%; Polyethylene Glycol: 60%; Tween: 1% is mixed and made into capsule liquid, separately makes capsule material glue by gelatin, glycerol, purified water, capsule liquid and capsule material glue is made soft capsule by capsule filling machine.
Embodiment ten:
The preparation of medicinal composition soft capsule agent: resveratrol composition: 55%; Cera Flava: 10%; Polyethylene Glycol: 30%; Tween: 5% is mixed and made into capsule liquid, separately makes capsule material glue by gelatin, glycerol, purified water, capsule liquid and capsule material glue is made soft capsule by capsule filling machine.
Embodiment 11:
The preparation of medicinal composition soft capsule agent: resveratrol composition: 34%; Cera Flava: 20%; Polyethylene Glycol: 40%; Tween: 6% is mixed and made into capsule liquid, separately makes capsule material glue by gelatin, glycerol, purified water, capsule liquid and capsule material glue is made soft capsule by capsule filling machine.
Embodiment 12:
The preparation of pharmaceutical composition hard capsule: resveratrol composition: 20%; Dextrin: 60%; To drop in mixer mixing 10 minutes, add ethanol 1% as wetting agent, mix 5 ~ 10 minutes, mixed material pelletization, drying, add microcrystalline Cellulose 19%, granulate, capsule-filling, obtain hard capsule.
Embodiment 13:
The preparation of pharmaceutical composition hard capsule: resveratrol composition: 50%; Dextrin: 40%; To drop in mixer mixing 20 minutes, add ethanol 2% as wetting agent, mix 10 minutes, mixed material pelletization, drying, add microcrystalline Cellulose 8%, granulate, capsule-filling, obtain hard capsule.
Embodiment 14:
The preparation of pharmaceutical composition hard capsule: resveratrol composition: 29%; Dextrin: 50%; To drop in mixer mixing 30 minutes, add ethanol 1% as wetting agent, mix 5 minutes, mixed material pelletization, drying, add microcrystalline Cellulose 20%, granulate, capsule-filling, obtain hard capsule.
Embodiment 15:
The preparation of pharmaceutical composition hard capsule: resveratrol composition: 28%; Dextrin: 60%; To drop in mixer mixing 30 minutes, add ethanol 2% as wetting agent, mix 5 minutes, mixed material pelletization, drying, add microcrystalline Cellulose 10%, granulate, capsule-filling, obtain hard capsule.
Embodiment 16:
The preparation of medicament composition dropping pills agent: resveratrol composition: 80%; Polyethylene Glycol: 20% mix homogeneously, heating, move into the drip irrigation of pill dripping machine, medicinal liquid drops in low temperature liquid Paraffin, and removing liquid Paraffin, selects ball, obtain drop pill.
Embodiment 17:
The preparation of medicament composition dropping pills agent: resveratrol composition: 95%; Polyethylene Glycol: 5% mix homogeneously, heating, move into the drip irrigation of pill dripping machine, medicinal liquid drops in low temperature liquid Paraffin, and removing liquid Paraffin, selects ball, obtain drop pill.

Claims (6)

1. a medicament for stifling cervical region, is characterized in that: described medicament is configured by ratio of weight and the number of copies by following medicine and forms: Radix Puerariae 50-60 part, Ramulus Cinnamomi 15-20 part, Caulis Spatholobi 35-40 part, Os Draconis 30-35 part, Concha Ostreae 30-35 part, Pheretima 15-20 part, Semen Vaccariae 10-15 part, Caulis Seu Folium Euonymi Fortunei 10-15 part, Folium Apocyni Veneti 10-15 part, Medulla Junci 5-10 part, Semen Nelumbinis 15-20 part, Folium Artemisiae Argyi 10-15 part, Scolopendra 1-2 part, Gypsum Fibrosum 3-5 part.
2. the medicament of a kind of stifling cervical region as claimed in claim 1, is characterized in that: described medicament can apply to treat cervical region not to be loosened and the strain state that causes for a long time.
3. the medicament of a kind of stifling cervical region as claimed in claim 1, is characterized in that: described medicament can apply to alleviate and cause sour swollen strain symptom with all the other position muscle for the treatment of due to prolonged exercise.
4. the medicament of a kind of stifling cervical region as claimed in claim 1, is characterized in that: described medicament can be used in electric heating and fumigate in medicated pillow, heating fumigating treatment neck strain disease.
5. the medicament of a kind of stifling cervical region as claimed in claim 1, is characterized in that: described medicament can directly carry out fumigation treatment neck strain disease and the swollen strain symptom of muscle acid with adding water boil.
6. the medicament of a kind of stifling cervical region as claimed in claim 1, is characterized in that: described medicament can boil to join in insulation heating pad with hot water and carry out hot compression therapy neck strain disease.
CN201410716796.0A 2014-12-02 2014-12-02 Drug for fumigating neck Pending CN104383146A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410716796.0A CN104383146A (en) 2014-12-02 2014-12-02 Drug for fumigating neck

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410716796.0A CN104383146A (en) 2014-12-02 2014-12-02 Drug for fumigating neck

Publications (1)

Publication Number Publication Date
CN104383146A true CN104383146A (en) 2015-03-04

Family

ID=52601170

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410716796.0A Pending CN104383146A (en) 2014-12-02 2014-12-02 Drug for fumigating neck

Country Status (1)

Country Link
CN (1) CN104383146A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104473996A (en) * 2014-12-04 2015-04-01 莫海棠 Resveratrol pharmaceutical composition and application thereof
CN104623020A (en) * 2015-02-09 2015-05-20 上海和森生物科技有限公司 Fumigating bacteriostatic liquid

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102217883A (en) * 2011-03-17 2011-10-19 上海韬鸿化工科技有限公司 Chinese medicinal pillow capable of treating cervical spondylopathy
DE102011085413A1 (en) * 2011-10-28 2013-05-02 Dr. Willmar Schwabe Gmbh & Co. Kg Use of extracts from Filipendula for the treatment and prophylaxis of chronic pain conditions
CN103083556A (en) * 2012-12-11 2013-05-08 宋协勘 Traditional Chinese medicine for treating cervical spondylosis

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102217883A (en) * 2011-03-17 2011-10-19 上海韬鸿化工科技有限公司 Chinese medicinal pillow capable of treating cervical spondylopathy
DE102011085413A1 (en) * 2011-10-28 2013-05-02 Dr. Willmar Schwabe Gmbh & Co. Kg Use of extracts from Filipendula for the treatment and prophylaxis of chronic pain conditions
CN103083556A (en) * 2012-12-11 2013-05-08 宋协勘 Traditional Chinese medicine for treating cervical spondylosis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
徐三文: "《颈椎病妙法良方大全》", 31 May 2013, 华中科技大学出版社 *
王敬善等: "颈椎舒治疗颈椎综合征180例", 《山东中医杂志》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104473996A (en) * 2014-12-04 2015-04-01 莫海棠 Resveratrol pharmaceutical composition and application thereof
CN104623020A (en) * 2015-02-09 2015-05-20 上海和森生物科技有限公司 Fumigating bacteriostatic liquid
CN104623020B (en) * 2015-02-09 2020-05-12 上海和森生物科技股份有限公司 Fumigating antibacterial liquid

Similar Documents

Publication Publication Date Title
CN104189034A (en) External patch with muscle and bone soothing effect and preparation method of external patch
CN101816736B (en) Chinese medicament capsule for curing nasosinusitis
CN101524450B (en) Oral traditional Chinese medicine for setting bones and relieving rigidity of muscles and preparation method thereof
CN103446264A (en) Physical therapy liquid for treating neck-shoulder and lumbocrural pains and preparation method thereof
CN107184782A (en) External medicine composition, preparation method and applications
CN102309723A (en) Traditional Chinese medicine composition for treating arthralgia and preparation method of ointment thereof
CN102008610A (en) Traditional Chinese medicine composition for curing hyperosteogeny
CN102716210B (en) Traditional Chinese medicine for treating rheumatism and production method thereof
CN102008551B (en) Medicinal composition for treating pains of necks, shoulders and arms and preparation method and application thereof
CN104383146A (en) Drug for fumigating neck
CN102018941A (en) Chinese medicinal composition for treating children spastic cerebral paralysis
CN100548368C (en) The Miao herb liniment of treatment neck-shoulder pain, lumbago and leg pain
CN105343207A (en) Formulation of plaster
CN102805847B (en) Medicine for treating arthralgia
CN101518579B (en) Pressure stabilizing deoppilant and preparation process
CN105267703A (en) Traditional Chinese medicine for treating cervical spondylosis
CN100409877C (en) Chinese medicine preparation for treating hyperosteogeny
CN101569660B (en) External traditional Chinese medicine for relaxing muscles, stimulating blood circulation, diminishing inflammation and relieving pain and preparation method thereof
CN101297954B (en) Unbilical medicament for treating cough and preparation thereof
CN100394966C (en) Chinese medicine preparation for treating wind-cold disease, and its preparing method
CN108904656A (en) The pharmaceutical composition and its preparation method and application for treating cervical spondylosis or lumbar vertebra disease
CN103623096B (en) Hemiplegia xingnao zaizao pill and preparation method thereof
CN101897857A (en) Traditional Chinese medicine pill for curing lumbago
CN102579617A (en) Traditional Chinese medicine capsule for treating chronic neck, shoulder, waist and leg pains and processing method of same
CN107281444B (en) Analgesic pharmaceutical composition and preparation method and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150304

WD01 Invention patent application deemed withdrawn after publication